FDA and Pepsi to Add Narcan to Mountain Dew to Fight Heroin Epidemic

Share This Article


Purchase, NY—PepsiCo announced plans today to join the battle in America’s heroin epidemic by supplementing its Mountain Dew product formula with Narcan or Naloxone, the drug that reverses the effects of opiates like heroin and has saved thousands of lives from heroin overdoses over the last few years.

“The decision was easy,” said PepsiCo Vice President Alan Coch.  Marketing research conducted by PepsiCo showed that 98.6% of heroin addicts in the United States consume three to four Mountain Dew products per day.  “That’s when we knew we needed to act,” added Coch.

And PepsiCo did.  In conjunction with research from the U.S. Food and Drug Administration, PepsiCo will add Narcan to its Mountain Dew soft drink recipe starting next year.

According to the FDA, the move to use Narcan as a health supplement was not surprising.  In fact, the FDA was in the process of approving Narcan as a regular nutritional supplement similar to riboflavin and niacin in basic grains like flour and rice – even establishing its own “Percent Daily Value.”

“With so many people taking some form of opiate – whether it’s prescribed or not – we felt it would be in the best interest of public health to cut opiates off at the pass,” said FDA director Steven Heine.  “Ideally, Narcan will be waiting in the blood of all Americans for opiates, then suppress them when they come flooding in.  What other option do we have at this point?”

“I think it’s a great idea,” says Boston Police Officer Patrick McMillan about PepsiCo’s plan.  “You can ask any police officer, whenever someone is using, buying, or overdosing on heroin there is always a Mountain Dew bottle nearby.  It’s uncanny.”



About the Author

Henry Calgues
Henry is the creator of Blights and Sirens and law enforcement's most assumed investigative journalist.

Be the first to comment on "FDA and Pepsi to Add Narcan to Mountain Dew to Fight Heroin Epidemic"

Leave a comment

Your email address will not be published.